Tirzepatide 110mg*10vials

描述

Core Features
$\ge 99.0\%$ Ultra-High Purity & 110mg Industrial-Scale Batch Homogeneity: This product is manufactured using industry-leading automated, large-scale Solid-Phase Peptide Synthesis (SPPS) technology. Given Tirzepatide’s complex 39-amino acid chain structure and $\text{C}_{20}$ fatty diacid side chain, achieving a 110mg fill weight presents significant challenges regarding synthesis control, crude peptide desalting, and advanced conformational purification. We employ a precise industrial-grade reversed-phase preparative HPLC (RP-HPLC) process to rigorously eliminate by-products such as truncated chains and non-specific side-chain modifications. Within this 110mg high-capacity format, every vial guarantees a baseline purity of $\ge 99.0\%$, providing a clean, interference-free matrix for large-scale in vitro receptor affinity assays and long-term in vivo animal metabolic model studies.
Synergistic Twin-Incretin Signaling Mechanism: As an innovative dual-receptor agonist, Tirzepatide achieves synergistic effects through a unique dual-target mechanism: the GIPR pathway regulates lipid homeostasis in adipose tissue and enhances metabolic sensitivity to insulin, while the GLP-1R pathway works in concert to control glucose-dependent insulin release and regulate satiety and overall energy balance. The 110mg super-sized format ensures that research institutions can establish a highly consistent experimental baseline when preparing long-term, standardized “Master Stock” solutions.
Advanced Cryo-Lyophilization Lock Process: The 110mg high-concentration peptide powder undergoes moisture sublimation at ultra-low temperatures ($-80^\circ\text{C}$) and near-absolute vacuum conditions, resulting in a uniform, robust, and collapse-free “lyophilized cake” with a snowflake-like crystalline structure. This process ensures that the spatial secondary structure of the peptide molecules remains in a deeply locked “frozen state” throughout extended research storage periods, significantly enhancing biological activity stability after reconstitution.

🛠️ Technical Specifications & Parameters
Product Specification: 110 mg / Vacuum-Sealed Glass Vial
Molecular Formula: $\text{C}_{225}\text{H}_{348}\text{N}_{48}\text{O}_{68}$
Appearance: White to off-white sterile lyophilized powder / intact solid cake
Validation: Accompanied by original manufacturer HPLC purity chromatograms and MS molecular weight verification reports.

❄️ Storage & Shipping Ironclad Policy
Laboratory Storage Protocol: Upon receipt, the product must be immediately stored in an explosion-proof, research-grade ultra-low temperature freezer ($-20^\circ\text{C}$ to $-80^\circ\text{C}$) while in its unreconstituted state. Researchers are strongly advised to aliquot the product into single-experiment doses within a laminar flow hood and freeze them to establish a standardized master stock; repeated freeze-thaw cycles are strictly prohibited.
Pharmaceutical-Grade Cold Chain Shipping: The 110mg Tirzepatide is shipped via express service using high-density, reinforced five-layer insulated foam boxes combined with high-capacity phase-change gel packs. This ensures the peptide’s higher-order spatial conformation remains “locked in a frozen state” while traversing diverse global climate zones.

📝 Research Limitations & Compliance
⚠️ Strictly for Laboratory Research Use Only (RUO): This product (Tirzepatide 110mg) is a chemical reagent intended for cutting-edge life science research. In strict adherence to global biosafety and compliance standards, this product is restricted solely to academic research conducted in university laboratories, research institutes, or R&D centers of biopharmaceutical companies (e.g., experiments on cell receptor binding affinity, high-throughput drug screening, and long-term metabolic cohort monitoring in large animals). Any unauthorized use—including human clinical injection, oral administration, substitution for medical prescriptions, or use as an illicit weight-loss agent, performance-enhancing drug, or stimulant—is strictly prohibited. This platform enforces rigorous multi-level verification of the “End-Use Statement”; any order suspected of involving misuse will be unconditionally cancelled and reported to the relevant compliance authorities.